Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

January 1, 1998; Volume 39,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Palkovic, Stefan

    1. You have access
      Diagnosis of Recurrent Glioma with SPECT and Iodine-123-α-Methyl Tyrosine
      Torsten Kuwert, Burkhard Woesler, Carlo Morgenroth, Hartmut Lerch, Michael Schäfers, Stefan Palkovic, Peter Matheja, Wolfgang Brandau, Hansdetlef Wassmann and Otmar Schober
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 23-27;
  2. Park, Kyung-Ok

    1. You have access
      Technetium-99m-MIBI Uptake in Small Cell Lung Cancer
      Hee-Seung Bom, Young-Chul Kim, Ho-Cheon Song, Jung-Jun Min, Ji-Yeul Kim and Kyung-Ok Park
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 91-94;
  3. Park, Young-Ha

    1. You have access
      Pinhole SPECT Imaging in Normal and Morbid Ankles
      Yong-Whee Bahk, Soo-Kyo Chung, Young-Ha Park, Sung-Hoon Kim and Hyoung-Koo Lee
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 130-139;
  4. Pascali, Claudio

    1. You have access
      Prospective Evaluation of Fluorine-18-FDG PET in Presurgical Staging of the Axilla in Breast Cancer
      Flavio Crippa, Roberto Agresti, Ettore Seregni, Marco Greco, Claudio Pascali, Anna Bogni, Carlo Chiesa, Vinicio De Sanctis, Vincenzo Delledonne, Bruno Salvadori, Monica Leutner and Emilio Bombardieri
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 4-8;
  5. Patrick, Mark R.

    1. You have access
      Preclinical Characterization and In Vivo Imaging Studies of an Engineered Recombinant Technetium-99m-Labeled Metallothionein-Containing Anti-Carcinoembryonic Antigen Single-Chain Antibody
      Geoffrey A. Pietersz, Mark R. Patrick and Kerry A. Chester
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 47-56;
  6. Perez, Niuvis

    1. You have access
      Technetium-99m-Labeled Anti-EGF-Receptor Antibody in Patients with Tumor of Epithelial Origin: I. Biodistribution and Dosimetry for Radioimmunotherapy
      Normando Iznaga-Escobar, Leonel A. Torres, Alejo Morales, Mayra Ramos, Ivette Alvarez, Niuvis Pérez, Roberto Fraxedas, Oscar Rodríguez, Nelson Rodríguez, Rolando Pérez, Agustín Lage and Michael G. Stabin
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 15-23;
  7. Perez, Rolando

    1. You have access
      Technetium-99m-Labeled Anti-EGF-Receptor Antibody in Patients with Tumor of Epithelial Origin: I. Biodistribution and Dosimetry for Radioimmunotherapy
      Normando Iznaga-Escobar, Leonel A. Torres, Alejo Morales, Mayra Ramos, Ivette Alvarez, Niuvis Pérez, Roberto Fraxedas, Oscar Rodríguez, Nelson Rodríguez, Rolando Pérez, Agustín Lage and Michael G. Stabin
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 15-23;
  8. Piepsz, Amy

    1. You have access
      Regional Stability of Cerebral Blood Flow
      Marianne Tondeur, Hamphrey Ham and Amy Piepsz
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 216;
  9. Pietersz, Geoffrey A.

    1. You have access
      Preclinical Characterization and In Vivo Imaging Studies of an Engineered Recombinant Technetium-99m-Labeled Metallothionein-Containing Anti-Carcinoembryonic Antigen Single-Chain Antibody
      Geoffrey A. Pietersz, Mark R. Patrick and Kerry A. Chester
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 47-56;
  10. Piwnica-worms, David

    1. You have access
      Novel Technetium (III)-Q Complexes for Functional Imaging of Multidrug Resistance (MDR1) P-Glycoprotein
      Carolyn L. Crankshaw, Mary Marmion, Gary D. Luker, Vallabhaneni Rao, Julie Dahlheimer, B. Daniel Burleigh, Elizabeth Webb, Karen F. Deutsch and David Piwnica-Worms
      Journal of Nuclear Medicine January 1, 1998, 39 (1) 77-86;
« Previous (Pages : 1 2 ... 2) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 39, Issue 1
January 1, 1998
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire